Andere Kunden interessierten sich auch für
![Synthese strukturell und funktionell modifizierter Nukleoside und Nukleotide zur Untersuchung von DNA-Konformationen und Protein-DNA-Interaktionen]( "Synthese strukturell und funktionell modifizierter Nukleoside und Nukleotide zur Untersuchung von DNA-Konformationen und Protein-DNA-Interaktionen")
Synthese strukturell und funktionell modifizierter Nukleoside und Nukleotide zur Untersuchung von DNA-Konformationen und Protein-DNA-Interaktionen48,25 €![Chemoinformatics: Theory, Practice, & Products]( "Chemoinformatics: Theory, Practice, & Products")
Chemoinformatics: Theory, Practice, & Products116,99 €![Catalytic and Biocatalytic Methods for the Efficient Synthesis of Biologically Relevant Non-Proteinogenic Amino Acids]( "Catalytic and Biocatalytic Methods for the Efficient Synthesis of Biologically Relevant Non-Proteinogenic Amino Acids")
Catalytic and Biocatalytic Methods for the Efficient Synthesis of Biologically Relevant Non-Proteinogenic Amino Acids29,99 €![Active Site-Directed Enzyme Inhibitors]( "Active Site-Directed Enzyme Inhibitors")
Active Site-Directed Enzyme Inhibitors181,99 €![Small-Molecule Transcription Factor Inhibitors in Oncology]( "Small-Molecule Transcription Factor Inhibitors in Oncology")
Small-Molecule Transcription Factor Inhibitors in Oncology213,99 €![Design and Synthesis of Modified SNARE Proteins with Respect to the ¿¿SNAP/NSF Mediated Disassembly]( "Design and Synthesis of Modified SNARE Proteins with Respect to the ¿¿SNAP/NSF Mediated Disassembly")
Design and Synthesis of Modified SNARE Proteins with Respect to the ¿¿SNAP/NSF Mediated Disassembly33,00 €![Chemistry of Renewables]( "Chemistry of Renewables")
Chemistry of Renewables75,99 €
Michael D. Wendt
Protein-Protein Interactions as Drug Targets
Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes , Jeremy Murray , Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Nicholas A. Meanwell , David R. Langley
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus
Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor
Protein-Protein Interactions as Drug Targets
Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes , Jeremy Murray , Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Nicholas A. Meanwell , David R. Langley
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus
Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor